CoChat

MIF Receptor CD 74 is Restricted to Microglia/Macrophages, Associated with a M 1‐Polarized Immune Milieu and Prolonged Patient Survival in Gliomas

Open access
Zeiner, Pia S., Preusse, Corinna, Blank, Anna‐Eva, Zachskorn, Cornelia, Baumgarten, Peter, Caspary, Lixi, Braczynski, Anne K., Weissenberger, Jakob, Bratzke, Hansjürgen, Reiß, Sandy, Pennartz, Sandra, Winkelmann, Ria, Senft, Christian, Plate, Karl H., Wischhusen, Jörg, Stenzel, Werner, Harter, Patrick N., Mittelbronn, Michel · 2015 · Brain Pathology
Cited by 108

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The macrophage migration inhibitory factor (MIF) receptor CD 74 is overexpressed in various neoplasms, mainly in hematologic tumors, and currently investigated in clinical studies. CD 74 is quickly internalized and recycles after antibody binding, therefore it constitutes an attractive target for antibody‐based treatment strategies. CD 74 has been further described as one of the most up‐regulated molecules in human glioblastomas. To assess the potential relevance for anti‐CD 74 treatment, we determined the cellular source and clinicopathologic relevance of CD 74 expression in human gliomas by immunohistochemistry, immunofluorescence, immunoblotting, cell sorting analysis and quantitative polymerase chain reaction (qPCR). Furthermore, we fractionated glioblastoma cells and glioma‐associated microglia/macrophages (GAMs) from primary tumors and compared CD 74 expression in cellular fractions with whole tumor lysates. Our results show that CD 74 is restricted to GAMs in vivo, while being absent in tumor cells, the latter strongly expressing its ligand MIF. Most interestingly, a higher amount of CD 74‐positive GAMs was associated with beneficial patient survival constituting an independent prognostic parameter and with an anti‐tumoral M 1 polarization. In summary, CD 74 expression in human gliomas is restricted to GAMs and positively associated with patient survival. In conclusion, CD 74 represents a positive prognostic marker most probably because of its association with an M 1‐polarized immune milieu in high‐grade gliomas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bpa.12194

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 108

Metadata

Authors
Zeiner, P. S., Preusse, C., Blank, A., Zachskorn, C., Baumgarten, P., Caspary, L., Braczynski, A. K., Weissenberger, J., Bratzke, H., Reiß, S., Pennartz, S., Winkelmann, R., Senft, C., Plate, K. H., Wischhusen, J., Stenzel, W., Harter, P. N., & Mittelbronn, M.
Venue
Brain Pathology
Publisher
Wiley
Published
2014-11-20
Volume
25
Issue
4
Pages
491-504
ISSN
  • 1015-6305 (ISSN-L)
  • 1750-3639
OpenAlex
W1960665172
Cited by
108
References
3
FWCI
2.59
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MIF Receptor CD 74 is Restricted to Microglia/Macrophages, Associated with a M 1‐Polarized Immune Milieu and Prolonged Patient Survival in Gliomas. https://app.cochat.ai/papers/10.1111/bpa.12194
The paper
Zeiner, P. S., Preusse, C., Blank, A., Zachskorn, C., Baumgarten, P., Caspary, L., Braczynski, A. K., Weissenberger, J., Bratzke, H., Reiß, S., Pennartz, S., Winkelmann, R., Senft, C., Plate, K. H., Wischhusen, J., Stenzel, W., Harter, P. N., & Mittelbronn, M. (2015). MIF Receptor CD 74 is Restricted to Microglia/Macrophages, Associated with a M 1‐Polarized Immune Milieu and Prolonged Patient Survival in Gliomas. Brain Pathology. https://doi.org/10.1111/bpa.12194

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.